Certified by Founder
Lodge
JURA Bio, Inc.
start up
United States
- Somerville, MA
- 25/09/2023
- Unknown
- $16,100,000
CAR-T is for more than just oncology. Using the full potential of gene editing, we are creating a therapeutic platform for cell based therapies that are not just disease modifying: they are curative and definitive.
- Industry Pharmaceutical Manufacturing
- Website https://www.jura.bio/
- LinkedIn https://www.linkedin.com/company/jurabio/about/
Golden Analytics | $7,000,000 | (Apr 9, 2026)
HexemBio | $10,400,000 | (Apr 9, 2026)
E2 - Endovascular Engineering | $80,000,000 | (Apr 9, 2026)
True Footage | $40,000,000 | (Apr 9, 2026)
Petwealth | $1,700,000 | (Apr 9, 2026)
Pomo | $4,500,000 | (Apr 9, 2026)
Aria Networks, Inc. | $125,000,000 | (Apr 9, 2026)
Trent AI | $13,000,000 | (Apr 9, 2026)
GoSats - The simplest onramp to Digital Assets in India | $5,000,000 | (Apr 9, 2026)
Life Biosciences | $80,000,000 | (Apr 9, 2026)
Noon | $44,000,000 | (Apr 7, 2026)
Miravoice | $6,300,000 | (Apr 7, 2026)